CDC advisers recommend an additional dose of the Covid-19 vaccine for certain immunocompromised people
Vaccine advisers to the US Centers for Disease Control and Prevention voted on Friday to recommend an extra dose of Covid-19 vaccine for some immunocompromised people.
The US Food and Drug Administration gave emergency use authorization Thursday night for a third dose in certain patients who are likely to have had a poor immune response to two doses of either Pfizer's or Moderna's vaccine. There's not enough data to discuss the possibility for an extra dose of Johnson & Johnson's one-shot Covid-19 vaccine, the FDA said.
It has been known for months that Covid-19 vaccines might not work well for this group. The hope was that vaccination rates overall would be so high so that the"herd" would protect them. But it didn't work out that way -- about a third of eligible people in the US have not received even one dose of a Covid-19 vaccine.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC Now Recommends Pregnant People Get the COVID-19 VaccineThe CDC is following the ACOG and now officially recommending that all pregnant people get the COVID-19 vaccine as cases rise due to the Delta variant. Read more about the announcement here.
Read more »
CDC urges COVID-19 vaccines during pregnancy as delta surgesExpectant women run a higher risk of severe illness and pregnancy complications from the coronavirus.
Read more »
FDA OKs 3rd COVID-19 vaccine dose for immunocompromised peopleThe onus will now shift to the CDC, which must decide whether to formally recommend the extra doses.
Read more »
FDA Authorizes Extra Covid-19 Vaccine Dose For Those With Weakened Immune SystemsThe FDA's decision comes at a time when the U.S. is hit by a new wave of infections fueled by the more infectious delta variant.
Read more »
Moderna's Covid-19 vaccine protects against Delta variant, study findsModerna's Covid-19 vaccine protects people for at least six months and likely longer -- even against new variants, researchers reported Thursday.
Read more »